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Anorexia nervosa (AN) is a severe eating disorder affecting around 1 per 100 persons.
However, the knowledge about its underlying pathophysiology is limited. To address the
need for a better understanding of AN, an animal model was established early on in
the late 1960’s: the activity-based anorexia (ABA) model in which rats have access to a
running wheel combined with restricted food access leading to self-starving/body weight
loss and hyperactivity. Both symptoms, separately or combined, can also be found in
patients with AN. The aim of this systematic review was to compile the current knowledge
about this animal model as well as to address gaps in knowledge. Using the data bases
of PubMed, Embase and Web of science 102 publications were identified meeting the
search criteria. Here, we show that the ABA model mimics core features of human AN
and has been characterized with regards to brain alterations, hormonal changes as well
as adaptations of the immune system. Moreover, pharmacological interventions in ABA
animals and new developments, such as a chronic adaptation of the ABA model, will
be highlighted. The chronic model might be well suited to display AN characteristics but
should be further characterized. Lastly, limitations of the model will be discussed.
Keywords: eating disorder, food restriction, hypophagia, hyperactivity, mice, rats, self-starvation, weight loss
INTRODUCTION
Anorexia nervosa (AN) is characterized by underweight, self-induced weight loss achieved by
food restriction or increased physical activity, endocrine alterations, and disturbance of body
image affecting mostly young women with a 12-month prevalence of 0.4% among adolescents
and young adults (1). The loss of body weight resulting in body mass index (BMI) values under
17.5 kg/m2 leads to various somatic symptoms affecting humoral and central nervous signaling as
well as cardiovascular and gastrointestinal functions (2). To fulfill the diagnostic DSM-V criteria of
anorexia nervosa a patient must show a restriction of energy intake inducing low body weight, a
fear of gaining weight or behavior preventing weight gain as well as a disturbance of body image or
lack of understanding of the danger of low body weight. Two subtypes of anorexia nervosa can be
distinguished: restrictive AN characterized by restrictive calorie intake and binge-purging AN with
self-induced vomiting (or other means to purge). It is to note that patients with AN often have
psychiatric comorbidities such as affective, anxiety, obsessive-compulsive, and substance abuse
disorders (3). These complications account for the high annual mortality rate of the disease, namely
of 5.4 deaths per 1,000 person-years, representing the highest mortality rate among all psychiatric
diseases (4).
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Therapeutic interventions encompass nutritional and
psychotherapy as well as—where applicable—drug therapy;
however, the relapse rate is high ranging between 35 and
41% within 18 months (5). Consequently, there is a need
for more efficient therapeutic options which requires better
understanding of the underlying pathomechanisms responsible
for the development of AN. To increase the knowledge about
diseases, animal models depicting alterations of the disease can
be very helpful.
In the late 1960’s, core features of AN, namely hyperactivity,
reduction of food intake and weight loss were observed in rats
exposed to food restriction combined with access to a running
wheel. Those animals increased their activity (6) and reduced
food intake (7) leading to self-starvation and hyperactivity
further aggravating weight loss. This negative relationship
between food intake and activity seemed counterintuitive at
first; however, subsequently it was hypothesized that an increase
of activity allows animals/individuals to reach an area with
stable food sources, thereby securing survival (8). Moreover,
hyperactivity was also shown to suppress appetite (8) and to be
an attempt to avoid a drop of body temperature (9). Additionally,
in patients suffering from AN the drive for hyperactivity is
positively correlated with anxiety, suggesting increasing activity
as a mean to reduce anxiety (10).
Finally, the observation of self-starving in male rats which
had unlimited access to a running wheel and restricted (1 h/day)
access to food led to the establishment of ABA as a model of
AN (11). Noteworthy, food-restricted male animals without a
running wheel stabilized their body weight on a lower level,
pointing toward the great importance of activity in this animal
model (11). Consequently, the model was termed activity-based
anorexia (ABA), sometimes also called exercise-induced anorexia
or food restriction-induced hyperactivity (11). The standard
ABA protocol consists of a 1–2 h feeding period during the
light or dark phase, combined with a 22–24 h wheel access
(11), leading to increasing hyperactivity and decreasing food
intake over time. In contrast, when food access is not restricted
in time but a fixed amount of food is given in the “semi-
starvation-induced hyperactivity” model, no (further) reduction
in food intake can be observed as indicated by similar intake
of food in food restricted animals with and without access
to a wheel (12). Thus, only ABA depicts a reduction of food
intake/loss of appetite as observed in human AN. Most of the
more recent ABA protocols include an acclimatization period
Abbreviations: 2DG, 2-deoxy-D-glucose; 5-HT, serotonin; α-MSH, alpha-
melanocyte stimulating hormone; ABA, activtiy-based anorexia; ACTH,
adrenocorticotropic hormone; AgRP, Agouti-related protein; AN, anorexia
nervosa; ARC, arcuate nucleus; BDNF, Brain-derived neurotrophic factor; BMI,
body mass index; CART, cocaine- and amphetamine-regulated transcript; CRF,
corticotropin-releasing factor; DMH, dorsomedial hypothalamus; ER, estrogen
receptor; GABA, Gamma-aminobutyric acid, GHS-R1a, growth hormone
secretagogue receptor 1a; HPA axis, hypothalamus-pituitary-adrenal axis; icv,
intracerebroventricular; IGF-2, insulin-like growth factor 2; ip, intraperitoneal; LC,
locus coeruleus; LEPR, leptin receptor; LHA, lateral hypothalamus; NAc, nucleus
accumbens; NMDA, N-methyl-D-aspartic acid; NPY, neuropeptide Y; NTS,
nucleus of the solitary tract; POMC, Pro-opiomelanocortin; PVN, paraventricular
nucleus; sc, subcutaneous; SD, Sprague Dawley; SSRI, selective serotonin reuptake
inhibitor; TLR4, Toll-like receptor 4; VTA, ventral tegmental area.
to the wheel prior to the start of food restriction. The ABA
protocol is usually pursued until a certain weight loss criterion,
frequently defined between 15 and 30% weight loss (11), is
reached. Additionally, a well-established variation of the ABA
protocol is the gradual reduction of food access over several
days (13). Most recently, several protocols describe prolonged
endurance of food restriction and wheel exposure over a period
of 55 days (14).
The present systematic review will present the current
knowledge on the ABA model, discuss alterations induced by
the model, highlight pharmacological options tested under these
conditions and also mention limitations of the model. Lastly,
gaps in knowledge will be addressed to stimulate further research.
METHODS
For the systematic data search the PRISMA guidelines were
applied. The data bases Pubmed—Medline and Web of Science
were searched using the following search terms: “Activity based
anorexia,” “Semi starvation induced hyperactivity,” “Exercise
induced anorexia,” and “Food restriction induced hyperactivity.”
Additionally, the EMBASE database was searched using the
terms “Anorexia nervosa AND rat” and “Anorexia nervosa
AND mouse.” The search was performed on October 20th
2018. Selection criteria applied were original publications,
animal studies and English language. Thus, the exclusion
criteria encompassed reviews, editorials, human studies, und
manuscripts written in another language than English. In the
manual screening all publications were identified investigating
rodents exposed to food restriction in combination with running
wheel access. Studies lacking one of these two characteristics were
not included into the final list of publications. However, some
are still mentioned in the manuscript to provide background
information or are used for comparison. Several additional
references were identified through review of the publication
lists of the included articles for background information. Of
those, nine were included into the final selection of references.
After selection, 102 publications were included in this systematic
review (Figure 1).
INFLUENCING FACTORS
Various versions of ABA protocols were used so far as
presented in Table 1. Consequently, several influencing
factors such as pre-exposure, ambient temperature and
sound, handling and maternal separation, diet and food
access, activity, sex, strain and genetics have been described
able to affect food intake, activity and thus body weight
loss during the development of ABA. These influencing
factors along with the outcomes are summarized in detail
in Table 2.
The following main conclusions can be drawn: Maternal
separation and daily handling should be omitted or be similar for
all animals, since it significantly influences weight loss (51, 52).
ABA occurs because wheel running interferes with adaptation
to the feeding schedule, which is omitted when the feeding
Frontiers in Nutrition | www.frontiersin.org 2 May 2019 | Volume 6 | Article 69
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FIGURE 1 | PRISMA flow chart.
schedule is introduced before the running wheel. Warm ambient
temperature could have an ameliorating effect on AN; thus,
a standard ambient temperature should be used in ABA to
reach the weight loss criterion. A feeding schedule for <2 h
in rats with standard chow and ad libitum access to water is
sufficient to induce hyperactivity and weight loss, both indicators
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of ABA. It can be assumed that it is useful to study activity levels
during the wheel adaption period in order to early on detect
low susceptibility to ABA (60, 101). Obviously, wheel access
is a crucial characteristic of ABA. Since pre-prandial activity
increases weight loss (119), food-anticipatory activity seems to be
an important factor for weight loss as well. Although in humans
AN is more prevalent in females, early studies often used adult
male rats to avoid the influence of hormones associated with both
development and reproduction. However, in rats studies focusing
on the effect of sex on ABA outcome showed that ABA seems to
develop more effectively and rapidly in males; noteworthy, also
food-anticipatory activity was more pronounced in males (13,
15). Since females take longer to reach the weight loss criterion
(44), in order to mimic and better understand human AN, female
animals should be examined in a more long term protocol.
Comparing different ages, younger rats develop ABA more
rapidly (123). To develop ABA in an adult rodent population
takes substantially longer than in adolescence, probably resulting
from the fact that—besides absence of significant body weight
gain during this period—escalation of running is often blunted
in adults compared to adolescent rats. As a consequence, adult
animals can often bemaintained in the paradigm for up to several
weeks without reaching the maximum weight loss criterion.
However, since younger animals are more vulnerable to ABA,
young animals typically cannot be maintained in the paradigm
for more than several days regardless of sex. Regarding the
investigation of different strains, C57BL/6J mice might not be
the first choice to examine effects of ABA (58), and A/J mice
might be more useful in long-term protocols (69). Similar strain
comparisons should be performed in rats.
EFFECTS OF ABA
Alterations of Hypothalamic Nuclei
and Transmitters
One of the main roles of the hypothalamus is to regulate
hunger, satiety, energy metabolism and ultimately body weight
(124). Areas of the hypothalamus involved in food and water
intake regulation encompass the arcuate nucleus [ARC, (125)],
the dorsomedial hypothalamus (126), lateral hypothalamus
[LHA (128)] the paraventricular nucleus [PVN (129)] and
ventral medial hypothalamus (130); thus, the effects of ABA
on the activity of the hypothalamus and its transmitters were
studied extensively.
ABA in female rats activated neurons in the supraoptic
nucleus [expressing oxytocin, related—among others—to anxiety
(131)] and ARC [participates in the regulation of food intake
as mentioned above (125)] compared to ad libitum fed rats
as assessed using the neuronal marker c-Fos when perfused
directly after the feeding period (74). Food-anticipatory activity
in the running wheel correlated with c-Fos expression in the
dorsomedial hypothalamus [DMH, involved in the regulation of
food and water intake as well as body weight (126)] in female
ABA Wistar rats (80). Interestingly, ABA rats on a random
feeding schedule, which did not develop food-anticipatory
behavior, displayed a negative correlation between neuronal
Frontiers in Nutrition | www.frontiersin.org 8 May 2019 | Volume 6 | Article 69
Schalla and Stengel Activity Based Anorexia
TABLE 2 | Factors influencing ABA outcome.
Influencing factor Effects on ABA outcome
Pre-exposure to:
Restricted feeding
↑ Survival rate of 75% (110)
Diminished food intake reduction, hyperactivity and body weight loss (103)
Feeding schedule ↓ Body weight loss (111)
Food restriction-induced weight reduction
Low initial body weight
Running wheel
↓ Food intake reduction, hyperactivity and body weight loss (103, 111)
No effect on ABA development (98)
No effect on ABA development (112)
↑ ABA vulnerability (113)
Deaccelerated self-starvation, no effect on percentage of survival (110)
↑ Body weight loss and hyperactivity, food intake reduction (111)
↑ Body weight loss and hyperactivity, food intake reduction (103)
High ambient temperature
Access to a warm plate
Deaccelerated body weight loss in male rats (55)
↓ Hyperactivity and body weight loss in male rats (56)
↓ Hyperactivity and body weight loss, food intake reduction (57)
Reversed hyperactivity, preserved food intake in female rats (53)
↓ Hyperactivity and body weight loss in female rats (9)
Sound attenuation condition Extended ABA duration, ↓ hyperactivity (54)
Daily handling
Maternal separation of 180min daily for 20
days postnatally
Maternal separation for 180 min/day for
14 days
↓ Body weight loss (52)
Delayed reaching the removal criterion of 20% weight loss (52)
↑ ABA resistance (greater survival) (51)
Accelerated weight loss, ↑ activity, ↓ food intake in females (114).
Prevented ABA in males (115).
Food presentation at irregular times
Different food access durations
Time of food presentation
Food type
Drinking
↑ body weight loss and hyperactivity, food intake reduction (102)
6 h/day: ↓ survival (69)
3 or 4 h/day: cessation of estrous cycle, body weight loss, food intake suppression and hyperactivity (107)
2 h/day: severe gastric lesions, ↑ mortality (107).
At the onset of dark phase: prevented body weight loss (111).
High fat chow/vegetable fat: prevented reaching of removal criterion (85)
0.88M sucrose: prevented hyperactivity and body weight loss (116)
Palatable food (2 h/day): binge eating (22).




Wheel inaccessibility 4 h before feeding: diminished body weight loss (111)
Induced sickness (118)
Activity levels before ABA induction strongly predicted outcome of ABA (60, 101)
↓ Body weight loss (119)
↑ Body weight loss (119)
Female sex
Male sex
↑ Food intake, hyperactivity, deaccelerated body weight loss (44)
↑ Body weight loss and hyperactivity, no ↑ vulnerability to ABA (120)
↑ Body weight loss and hyperactivity (121)
↓ Body weight loss and food intake reduction, ↑ hyperactivity during food intake period and post-prandial hyperactivity
(13, 15)
↓ Hyperactivtiy during food intake period (35).
↑ Food intake reduction, hyperactivity, accelerated body weight loss (44)
Body weight loss correlated with ↑ running (120)
↑ Mortality rate (20% weight loss in 3 days), body weight loss and food intake reduction, ↑
food-anticipatory/pre-prandial activity (13, 15)
↓ Food-anticipatory/pre-prandial activity (35)
Strain
Genetics
C57BL/6J mice: ↓ hyperactivity, DBA/2J mice: ↑ hyperactivity (58)
Brown Norway and Lewis rats: ↓ thymus weight (89)
A/J mice: longer survival (69).
Chromosome substitution strains 4, 12, 13: ↑ hyperactivity during the light phase hours/food restriction phase (122)
Lean-prone rats: ↑ hyperactivity and accelerated body weight loss (87)
Leptin receptor deficiency: prevented reaching weight loss criterion (87)
α4βδ-GABAAR KO female rats: ↑ body weight loss and hyperactivity, food intake reduction (35)
Reduced miR-340 expression: ABA resistance (105)
↑, increase; ↓, decrease.
activity in the ARC and body weight loss (80). Before food access
and during pre-prandial activity, c-Fos expression and ARC,
PVN as well as in the nucleus accumbens [NAc, involved in the
processing of motivation, aversion and reward, lesions result in
increased food intake and weight gain; (127)] was observed to be
reduced in male rats undergoing ABA when provided access to
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0.88M sucrose, but not after 0.002M saccharin in a comparable
sweetness, giving rise to an attenuating effect of sucrose on
wheel running possibly induced by inhibition of hypothalamic
activation through corticosterone (116).
Lateral hypothalamus electrical stimulation (100Hz and
25, 50, and 75% of the maximal stimulation amplitude) on
consecutive days during four test sessions significantly decreased
locomotor activity in female ABA rats with no effect on food
intake or survival time (72). Future studies should focus on other
brain areas targeted by electrical stimulation to alter features
of AN.
In female mice ABA induced an increase of hypothalamic
protein synthesis. These changes of the hypothalamic proteome
especially affected proteins involved in glycolysis or in citric
acid cycle (21), giving rise to an adaptively enhanced energy
metabolism. Additionally, proteins limiting oxidative stress
were altered (21). DNM1L, implicated in mitochondrial fission,
was overexpressed under conditions of ABA leading to an
increased number of mitochondria, while increased dynamin-1
and LC3II/LC3I ratio indicated an activation of autophagy (21).
Taken together, ABA leads to an adaptation of the hypothalamic
proteome inducing autophagy and mitochondrial changes.
Pro-Opiomelanocortin (POMC), Cocaine- and
Amphetamine-Regulated Transcript (CART),
Agouti-Related Protein (AgRP), and Neuropeptide
Y (NPY)
The protein POMC, cleaved into various active peptides such as
melanocyte-stimulating hormones, is essential in the regulation
of food intake inducing satiety; thus, its absence can lead
to obesity (132). Among others, POMC is expressed in the
hypothalamus (133). In female ABA rats, arcuate expression of
POMC protein was reduced 2-fold (61). In contrast, another
study reported a transient up-regulation of POMC mRNA
levels in the ARC, pointing toward increased anorexigenic
signaling in female ABA rats (64). This discrepancy might
be due to dynamics of peptide expression in the course of
ABA development. Similarly, food restriction 1 h food access
per day at the beginning of the dark phase), regardless of
the level of physical activity, elevated melanocortin receptor
(involved in POMC signaling) expression in the ventral medial
hypothalamus (134). This is likely of physiological importance
as intracerebroventricular (icv) infusion of AgRP, an orexigenic
peptide expressed in the ARC with inverse agonistic activity on
melanocortin 3 and 4 receptors (135), increased the survival rate
by decreasing physical hyperactivity and blunting suppression of
food intake (134). Conversely, chronic administration of alpha-
melanocyte stimulating hormone (α-MSH), an anorexigenic
cleavage product of POMC (136), into the lateral ventricle
stimulating the melanocortin receptors and the hypothalamus-
pituitary-adrenal (HPA) axis [mediating the response to stress,
regulating digestion, and energy expenditure as well as inhibiting
reproductive functions (137)] elevated running wheel activity
and reduced food intake in rats resulting in higher vulnerability
to develop ABA (63). Arcuate protein expression levels of AgRP
and NPY [orexigenic hypothalamic neuropeptide (138)] were
elevated 5-fold and correlated negatively with relative body
weight and white adipose tissue mass (61). A recent study
corroborated these data by showing that ABA in female Sprague
Dawley rats led to higher NPY, AgRP but also POMC expression
(48). Additionally, increased levels of NPY mRNA in the ARC
were observed in female ABA rats compared to those having
ad libitum access to food (139). In female rats exposed to a
feeding time of 2 h/day; daily icv infusion of NPY at the end of
the light phase over a period of 7 days accelerated development
of ABA by reducing food intake and increasing wheel running
(139). Combination of food restriction and enhanced physical
activity in male C57BL/6J mice elevated hypothalamic protein
expression of AgRP, while food restriction alone increased
NPY and AgRP, indicating that anorexic-like conditions disrupt
hypothalamic circuitries (140). Therefore, it can be hypothesized
that ABA induces alterations of neuropeptides including AgRP,
NPY, POMC, and CART in first order neurons (in e.g., ARC,
LHA) able to negatively impact on energy balance.
Endorphins
The peptide β-endorphin is also derived from POMC and
mainly expressed in the hypothalamus. Dynorphin-A is another
endorphin with opioid-like effects. In male rats voluntary
exercise under food-restricted conditions elevated β-endorphin
in the ARC and dynorphin-A in the supraoptic hypothalamic
nucleus following 2-deoxy-D-glucose (2DG) stimulation (38).
In addition, in the suprachiasmatic nucleus dynorphin-A was
increased (37). Female rats undergoing the ABA paradigm
did not display alterations of hypothalamic β-endorphin
concentration compared to controls (141). These observations in
ABA resemble data of increased opioid activity in humans with
AN (142); thus, further studies on the role of opioid signaling in
AN are warranted.
Central Orexin and Leptin
Female rats with a proactive stress-coping style to prenatal
stress, assessed by the defensive burying test, displayed elevated
hypothalamic mRNA orexin expression, higher levels of DNA
methylation of the orexin gene as well as reduced leptin levels
while their ghrelin levels were increased during ABA (48).
In male ABA rats, chronic leptin infusion using minipumps,
concomitantly to the initiation of food restriction for 7 days,
suppressed the 300% increase of baseline physical activity
observed in restrictively fed vehicle animals (12). Also, chronic
subcutaneous (sc) application of leptin after initiation (6 days) of
semi-starvation-induced hyperactivity abolished this alteration
(12). Chronic leptin treatment (icv via osmotic minipump, 4
µg/d) in female ABA rats decreased running wheel activity, food
intake, and increased energy expenditure by thermogenesis (65).
Similarly, in female rats undergoing ABA, acute central leptin
injections into the lateral ventricle and microinjection of leptin
into the ventral tegmental area at day 4 diminished running wheel
activity (79), pointing toward a role of decreased leptin signaling
in hyperactivity.
Corticotropin-Releasing Factor (CRF)
CRF, expressed in the PVN and stimulating adrenocorticotropic
hormone (ACTH) secretion, is a hallmark regulator of the HPA
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axis and thus involved not only in the stress response but
also energy metabolism (137). Seven-day running wheel access
increased CRF mRNA expression in the DMH, but not in the
PVN, of male rats (143). Similarly, ABA in female Sprague
Dawley rats did not alter CRF mRNA concentrations in the
PVN (86). Interestingly, female rats that developed ABA during
adolescence presented increased anxiety-like behavior associated
with increased expression levels of CRF mRNA in the PVN and
the central nucleus of the amygdala in adulthood, whereas food
restriction alone did not induce these changes (144). Another
study showed that ABA elevated c-Fos in CRF positive neurons
of the PVN and DMH (76). The effects of wheel running on meal
size could be reversed by icv injection of the CRF antagonist
α-helical-CRF(9−41), additionally increasing DMH CRF mRNA
expression (143), pointing toward a crucial role of CRF in the
development of ABA. In another study, icv injection of the
competitive CRF antagonist SHU9119 had no ameliorating effect
on ABA, while treatment with the inverse agonist AgRP(83−132)
did (64). Therefore, the role of CRF in the development and
maintenance of ABA needs further investigation.
Nesfatin-1
Nesfatin-1 is an anorexigenic neuropeptide found predominantly
in the hypothalamus (and peripherally in the gastric mucosa) also
involved in the modulation of gastrointestinal functions (145).
Phenotyping studies in female rats showed that following a 7-
day wheel acclimatization+14 day food restriction protocol with
or without a running wheel, the number of activated nesfatin-
1 immunoreactive cells was increased in the PVN, ARC, DMH,
dorsal raphe nucleus and the rostral raphe pallidus compared
to ad libitum fed and activity (running wheel) controls (75).
Also, food restricted rats showed a trend toward an increase of
NUCB2/nesfatin-1 (most antibodies do not distinguish between
full length NUCB2 and nesfatin-1) protein expression in the
PVN, ARC, LC, and DMH, while in rats with access to the
running wheel only no altered expression of nesfatin-1 was
observed compared to ad libitum fed control rats (75). The
differences between ABA and food restricted rats indicate central
alterations independent of a simple body weight reduction. Taken
together, alterations in expression patterns can be observed
in motor and higher food intake circuitries due to ABA,
likely underlying/contributing to the effects on food intake
and locomotor activity. These activity patterns resemble those
observed in humans with AN, e.g., altered cortical processing of
high and low-calorie food pictures compared to healthy controls
has been described (146).
Serotonin
Serotonin (5-HT) as one of the most important central
neurotransmitters is widely expressed in the human brain. It
is thus involved in various regulatory processes, modulating—
among others—mood, anxiety, aggression, and hunger (147).
The serotonin receptors can be subdivided into seven subtypes:
5-HT1-5-HT7, all of which are G-protein coupled receptors with
the exception of 5-HT3, which is an ion channel. Serotonin’s
appetite-suppressing effect is mainly mediated by 5-HT1B, 5-
HT2C and 5-HT6 receptors in the ARC and PVN (148). In
humans, evidence showing a robust effect of antidepressants
on body weight gain in AN is limited so far (149). However,
the combination of selective serotonin re-uptake inhibitors
(SSRI) with psychotherapy can exert positive effects on anxiety,
depression, and compulsive thoughts (150).
Dietary restriction inducing hyperactivity reduced central,
especially hypothalamic, serotonin signaling (151). A reduction
of serotonin concentration has also been observed in AN patients
(152). Daily administration of fluvoxamine (7 d, orally), a SSRI,
suppressed the increase in running activity after feeding without
affecting body weight loss or food intake in ABA rats (109).
In female ABA mice, chronic oral treatment with fluoxetine,
another SSRI, elevated food intake, and reduced activity without
any effects on survival (69). Similarly, female ABA rats, treated
ip with fluoxetine for 5 weeks, showed an increased food
intake, displayed decreased running activity and lost less weight
compared to saline treated rats (83).
Agonists with high affinity for the 5-HT1C receptor [located
in cortical and subcortical neurons of the hippocampus,
thalamus, and monoaminergic cell groups (153)] blocked semi-
starvation-induced increased running wheel activity in rats (108).
Daily sc injections of 8-OH-DPAT, an agonist of the 5-HT1A
receptor (found pre- and postsynaptically, ubiquitously located,
and stimulating cAMP formation in the respective neurons),
administered 40min before feeding for 10 days prevented
hyperactivity, subsequently reducing body weight loss in female
ABA rats (46). In contrast, hyperactivity, induced by restricted
access to food in female rats, was enhanced by acute sc injection
of 8-OH-DPAT (151), pointing toward different effects of 5-HT1A
and 5-HT7 activation in ABA and food-restricted animals.
Fenfluramine (continuously infused sc during 1 week), an
appetite suppressant activating 5-HT2C receptors and releasing
serotonin resulting in increased extracellular serotonin levels, did
not affect food intake, wheel running, body weight, hypothermia
or HPA axis activity, while inducing hypodipsia, elevated plasma
osmolality, and arginine-vasopressin expression levels in the
hypothalamus (62). In another study, ABA rats chronically
sc infused with fenfluramine using mini-pumps had a greater
susceptibility to ABA due to a reduction of food intake (43).
Similarly, fenfluramine (acute ip injection) administered 1.5 h
prior to the daily 2-h period of food access in female ABA
rats induced an accelerated weight loss (45). Female ABA rats
treated with parachlorophenylalanine, an irreversible tryptophan
hydroxylase inhibitor depleting serotonin, showed decreased
food intake and increased running activity resulting in increased
body weight loss (83), suggesting an inverse correlation between
central serotonergic activity and vulnerability to develop ABA.
Taken together, these observations indicate that signs of ABA
(weight loss, hyperactivity) can be intensified by increasing
peripheral 5-HT signaling, while centrally a reduction exerted a
similar effect.
Fluoxetine, another SSRI, was shown to exert various effects
on ABA animals. In detail, it decreased dynorphin-A content
under ABA conditions (37), induced a pathological elevation
of vasopressin in the suprachiasmatic hypothalamus, while a
physiological increase in plasma vasopressin was observed (37,
42). Additionally, it reduced oxytocin secretion in ABA animals,
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while increasing oxytocin in control animals (37, 42). Lastly,
fluoxetine had no effect on parameters like blood glucose, plasma
insulin or insulin-like growth factor 2 (IGF-2) concentrations in
ABA (154).
Alterations of Central Structures and
Transmitters Involved in
Reward-Motivated Learning
Eating behavior is strongly linked with the reward system. Also,
eating disorders may be interpreted as reward-dependent since
e.g., reducing eating is perceived as rewarding in AN (155). Thus,
various studies examined central areas involved in reward in the
context of ABA.
Examining brain activity using a micro PET-CT, increased
cerebral 18F-fluorodeoxyglucose uptake was observed in male
ABA rats in the mediodorsal thalamus [playing a role in
memory and cognition (156) and body weight regulation
(157)], ventral pontine nuclei and cerebellum [modulates motor
activity, involved in classical conditioning (158)] compared
to active and inactive ad libitum fed controls (71). On the
other hand, ABA was associated with a reduced uptake in
the left rhinal and bilateral insular cortex [responsible for
gustatory and viscerosensory processing; (127)] as well as
bilateral ventral striatum [involved in processing of motivation,
aversion and reward, lesions results in increased food intake
and weight gain; (127)] compared to control animals without
food restriction and without access to running wheels (71).
Noteworthy, brain metabolism in the cingulate [processing
reward by linking actions and emotions resulting in learning
(159)] and surrounding motor and somatosensory cortex was
positively correlated with body weight (71). These data suggest
a significant role of central structure involved in reward signaling
in the development and/or maintenance of ABA.
Similarly, electrical stimulation or an electrolytic lesion of the
mediodorsal thalamus did not affect signs of ABA in female rats
that already developed ABA, while a preventive lesion selectively
decreased hyperactivity in ABA later on (70). Future studies using
electrical stimulation should include additional brain areas to
possibly affect features of AN.
Dopamine
Dopamine expressed in the ventral tegmental area (VTA)
as part of the mesocorticolimbic dopamine system is a key
regulator of the reward and motivation system (160). The
dopamine receptors are categorized into two families; the D1
and D5 receptors belong to the D1-like family, which are G-
protein coupled, increase cAMP and can be mainly found
post-synaptically, while D2, D3, and D4 receptors represent
the D2-like family inhibiting cAMP formation and are located
both pre- and post-synaptically. In brief, stimulation of D1
receptors results in dilatation of cerebral vessels. D2 receptors
modulate motor activity similar to D4 receptors, while D3-
receptors, located in the limbic system and cortex, are involved
in cognition (161).
Restricted food access elevated mRNA expression levels of
neuronal cell adhesion molecule 1 (NCAM1), involved in the
formation and modulation of synaptic contacts in the VTA of
Balb/cJ female mice (67).Wheel running alone elevated mRNA
expression of the growth factor, brain-derived neutrotrophic
(BDNF) in the VTA. When both conditions were combined,
no effects on BDNF or NCAM1 mRNA expression within the
mesocorticolimbic pathway could be observed (67). Female A/J
inbredmice with typical signs of ABA showed elevated dopamine
D2 receptor expression in the caudate putamen (59). In female
ABA rats, dopamine release in the nucleus accumbens was found
not to be elevated during the initiation of food-anticipatory
behavior but it was increased during food intake; additionally,
serotonin levels were decreased and circadian activity was
diminished (78). An elevation of dopamine levels has also been
observed in AN patients (162).
As mentioned above, an effect of antidepressants on
significant body weight gain in patients with AN could not be
detected so far (149). Among psychotropic drugs, olanzapine,
a non-selective modulator of various neurotransmitter systems
such as dopamine signaling, was the only medication found
to accelerate weight gain and reduce mealtime anxiety in AN;
however, inconsistent data exist (150). In an ABA model, during
food-anticipatory activity (locomotor activity that occurrs 2 h
before the availability of food), levels of dopamine and its
metabolites in the striatum andmidbrain were upregulated (163).
Consequently, treatment of ABA BALB/cJ mice with olanzapine
(orally applied daily for 7 days) antagonizing dopamine and
serotonin receptors increased survival by decreasing food-
anticipatory activity (164). Similarly, ABA rats treated with
olanzapine (sc daily for 7 days using an osmotic minipump)
displayed a decreased running wheel activity rate, starvation-
induced hypothermia and activation of the HPA axis, indicated
by decreased levels of ACTH, corticosterone and adrenal weights
without affecting food intake, while body weight loss was
decreased and ABA development diminished (66). Daily oral
treatment with the D2/3 receptor antagonists eticlopride and
amisulpride in ABA Balb/cJ female mice decreased weight
loss and hypophagia, resulting in increased survival (68).
Additionally, amisulpride reduced weight loss and hypophagia
to a higher extent compared to olanzapine (68). Similarly,
the D3 receptor antagonist SB277011A or the D2 receptor
antagonist L-741,626 elevated survival (68). Also, application of
chlorpromazine, another dopamine receptor antagonist, reduced
hyperactivity, leading to a 75% decreased mortality (11). In
male rats, chlorpromazine (intraperitoneally, ip) blocked food
suppression after wheel running during the light phase in
an acute model of ABA (165). ABA rats treated chronically
with the non-selective dopaminergic D1 and D2 antagonist
cis-flupentixol reduced body weight loss and increased food
intake (77). The D1 receptor antagonist SCH23390 as well
as the D2 receptor antagonist raclopride (acute ip injection)
significantly decreased food-anticipatory activity compared to
controls, while co-administration of both showed an additional
effect on the reduction of food-anticipatory activity (163).
Noteworthy, dopamine D1-like antagonists such as SCH23390
did not alter survival (68). The hypothesis that antagonizing
dopamine signaling has beneficial effects by increasing food
intake and body weight and reducing hyperactivity in ABA
should be substantiated in future studies.
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Excitation of the reward pathway by means of a dual
viral strategy involving retrograde transport of Cre to the
ventral tegmental area and coincident injection of DREADD
receptors inducing recruitment of a large proportion of VTA-
NAc dopaminergic projections decelerated establishment of ABA
in female rats by increasing food intake, food-anticipatory
activity and reducing weight loss (93). In female rats a direct
correlation between the intensity of activity and the severity of
withdrawal symptoms, assessed following sc naloxone injection,
was observed; thus, ABA rats displayed the most withdrawal
symptoms compared to restrictively fed, ad libitum fed and
active controls (96). Taken together, these results indicate an
alteration of the reward system during ABA in line with abnormal
reward circuitries described in AN (166). Options to modulate
the reward system modulating the severity of ABA should be
examined further.
Alterations of Hippocampal Structures
and Transmitters
The hippocampus is responsible for transmitting memory
content from short to long-term memory (167). Restricted
feeding for 14 days increased the transcripts of the growth
factor BDNF in the hippocampus of Balb/cJ female mice (67),
suggesting a putative role of the hippocampus in ABA. In
contrast, female A/J inbred mice undergoing the standard
ABA protocol showed decreased BDNF expression in the
hippocampus (59). Similar to these inconsistent data of BDNF
alterations in ABA, studies on BDNF levels in AN have shown
variable results (168).
In adolescent female Sprague Dawley rats, cell proliferation in
the dentate gyrus and hilus region, but not in the subgranular
zone and in the surrounding dorsal hippocampus and in the
corpus callosum, was reduced after 3 days of ABA with a positive
correlation between cell proliferation and body weight/food
intake (29), indicating an effect of ABA in adolescents rather
on gliogenesis than on neurogenesis. Female ABA rats showed
reduced total dendritic length and dendritic branches in the
stratum radiatum of the dorsal hippocampus, responsible
for spatial learning and cognition; in contrast, branching
in stratum radiatum of the ventral hippocampus mediating
anxiety was elevated in ABA (24). Exercise mainly affected
stratum radiatum, while food restriction influenced the stratum
lacunosum moleculare in the dorsal and ventral regions (24),
pointing toward pathway-specific alterations in the hippocampus
due to ABA. ABA in female adolescent Sprague Dawley rats
increased branching of ventral hippocampal pyramidal cells,
while the same protocol in adulthood decreased branching of
ventral hippocampal pyramidal cells without any effects on
dendritic branching (25). The proportion of mature spines on
dendrites was also altered due to ABA: in adolescent female
ABA animals it resembled adult control animals since control
animals doubled branching from adolescence to adulthood
(25). The results underline the age-dependent vulnerability
of hippocampus plasticity to ABA. Noteworthy, relapse of
ABA decreased branching (25). Thus, the hippocampus is an
important structure implicated in the development of ABA.
Hippocampal Gamma-Aminobutyric Acid (GABA)
In the hippocampus of female ABA rats a 6-fold increase of
α4 subunits of α4βδ GABA receptors and a 130% increase of
δ subunits of α4βδ GABA receptors, sufficient to increase tonic
hippocampal inhibition, was observed compared to age-matched
control females (23). GABAergic inhibition in the hippocampus
strongly induces anxiety and additionally regulates plasticity
(169). Similarly to the findings in the hippocampus, in the
amygdala of female pubertal rats under ABA conditions an
increase of membranous α4 subunits near excitatory synapses on
dendritic shafts in the caudal basal amygdala accompanied by
intracellular elevation of α4 subunits was observed, indicating
a disinhibition of the excitability of the amygdala (26).
Hyperactivity during food restriction in ABA adolescent female
rats negatively correlated with α4βδ GABA receptor levels visible
within 2 days of food restriction (27), suggesting a protection
against ABA by inhibition of α4βδ-GABAARs in spines of CA1
pyramidal neurons suppressing physical activity.
A negative correlation was described between α4 subunit
concentration at spines of pyramidal cells of the hippocampal
CA1 with severity of ABA, measured as food restriction-elicited
running activity during ABA (170), suggesting a protective role
of α4 subunits counterbalancing the ABA-induced excitability of
CA1 pyramidal neurons.
Contact lengths of axo-somatic contacts made by GABAergic
axon terminals onto layer 5 pyramidal neurons were increased
by 40% in female ABA mice; thus, the proportion of L5P
perikaryal plasma membrane contacted by GABAergic terminals
was elevated accordingly (171). Additionally, in female ABA
mice a negative correlation was observed between contact length
in the anterior cingulate cortex and overall wheel activity after
food restriction and between contact length in the prelimbic
cortex and wheel running especially during food availability in
the restriction phase (171). Adolescent female C57BL/6 mice
that developed ABA with food access during the first 2 h of the
dark cycle all survived; when re-exposed to the same conditions
after recovery for 7–11 days only some were vulnerable to ABA
with those being vulnerable displaying a reduced GABAergic
innervation on cell bodies and dendrites in CA1 pyramidal cells
compared to resilient mice (32). In summary, this underlines that
GABAergic innervation of hippocampal structures contributes to
the protection of animals against ABA.
In rats, chlordiazepoxide (acute ip injection), a
benzodiazepine, suppressed the decrease of food intake
under conditions of ABA (172).
Hippocampal N-Methyl-D-Aspartat (NMDA)
While GABA is the main inhibitory, glutamate is the major
excitatory neurotransmitter in the brain (173). Hippocampal
NMDA, as part of glutamate receptors and ion channel protein,
is involved in modulating learning, memory processing, and
feeding behavior (174). Using electron microscopy hippocampal
synaptic NR2A-NMDA and NR2B-NMDA receptor levels were
observed to be increased in female ABA rats (31). In those
animals, ABA severity positively correlated with synaptic NR2B-
NMDA receptor levels (31). In rodents resilient to ABA
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that did not develop hyperactivity, reserve pools of NR2A-
NMDA receptors in spine cytoplasm correlated with the
suppressed physical activity (31). NR2A- and NR2B-NMDA
receptors were related to spinous prevalence of an F-actin
binding protein, drebrin, responsible for receptor insertion to
and retention from synaptic membranes (31), indicating that
increased NMDA receptor expression elevates the vulnerability
to ABA. Noteworthy, anti-NMDA receptor encephalitis in
humans, resulting in decreased receptor density, is also associated
with abnormal eating behavior (175).
Subchronic treatment with agmatine (ip, for 10 days), an
endogenous ligand of imidazoline and α2-adrenergic receptors
that additionally selectively blocks the NMDA subclass of
glutamate receptor channels, reduced hyperactivity, increased
food intake and normalized body weight of female ABA rats, also
decreasing corticosterone levels (106), probably resulting from
restored body weight and increased food intake.
Clonidine, an α2-adrenergic receptor agonist, inducing
sympatholytic effects such as a reduction of blood pressure
(176) via negative feedback mechanisms was also tested under
conditions of ABA. Chronic infusion of clonidine into the PVN
of male ABA rats resulted in a dose-related increase in the
susceptibility to ABA and a decrease in food intake; similarly, in
heavy animals an increased susceptibility to ABA was observed
after chronic infusion of clonidine into the PVN but without
effect on food intake or wheel activity (41). Male rats receiving
a continuous sc infusion of clonidine using osmotic minipumps
and exposed to ABA showed an increase of food intake at a lower
dose of clonidine and a stimulation of wheel activity at a higher
dose, with no effects on weight loss (40), indicating that centrally
applied clonidine increases the vulnerability to ABA, an effect
mimicked by higher peripheral doses presumably crossing the
blood-brain barrier.
Cannabinoids
A rich hippocampal expression of the type 1 cannabinoid (CB1)
receptor suggests an important role of cannabinoids in the
hippocampal network and memory formation (177).
ABA conditions increased absolute CB1 receptor binding
using (18)F-MK-9470 in all cortical and subcortical brain areas
in both sexes, which decreased again in the recovery phase (73).
Elevation of relative CB1 receptor binding was observed in the
hippocampus, inferior colliculus and entorhinal cortex in female
ABA rats, which also normalized with weight regain in the
recovery phase (73), giving rise to impaired endocannabinoid
transmission under conditions of ABA, a finding also reported
in humans with AN (178).
In male C57/BL6 mice undergoing ABA daily ip application
of the phytocannabinoid delta(9)-THC 30min before the dark
phase reduced survival but increased feeding in the animals
which did survive, while the anandamide analog OMDM-2
stimulated food intake without sufficiently reversing weight loss
(99). Subchronic ip THC treatment 30min before the onset of the
dark phase in female ABA rats transiently increased food intake
and also affected running wheel activity (179). The higher dose
also decreased body weight loss accompanied by reduced energy
expenditure and lipolysis (179). When combined with high fat
diet, THC had the same effects but to a greater extent (179).
Daily ip injection for 6 days with the CB1/CB2 receptor agonist
19-tetrahydrocannabinol or the CB1/CB2 receptor agonist CP-
55,940 decreased body weight loss, physical activity, and plasma
corticosterone levels while increasing leptin signaling in female
ABA rats (104). Noteworthy, treatment was initiated at the start
of a second ABA protocol after rats already experienced one
ABA and one recovery phase (104). Overall, the cannabinoid
system is able to increase food intake also under conditions of
ABA. Noteworthy, although the CB1 receptor is highly expressed
in the hippocampus and might mediate the effects mentioned
above via the hippocampus, it should be kept in mind that this
receptor is also found in the VTA and hypothalamus. It cannot be
excluded that the orexigenic effects observed after CB1 receptor
agonist application are mediated via VTA and hypothalamus, a
hypothesis which should be examined further.
Consequently, male rats that orally received the CB1 receptor
antagonist SR141716 over a period of 32 days prior to ABA
starved faster, lost weight faster and increased the wheel running
rate more rapidly compared to those without drug treatment
(88). Rats with the same drug treatment but lacking a functional
leptin receptor did not reach the starvation criterion of 25%
body weight loss (88). Additionally, they displayed reduced wheel
running as well as decreased levels of serotonin and its metabolic
products in the hypothalamus and neural-reward areas including
the nucleus accumbens compared to animals with the same
dysfunctionality but without drug administration, suggesting
an interaction between CB1 and leptin receptor signaling also
implicated in regulating energy balance (88).
Alterations in Widely Expressed
Transmitters Involved in Hyperactivity
Histamine
Histamine is a widely expressed transmitter signaling—among
others—via the Gq-protein coupled H1 receptor resulting in a
calcium release, involved in the regulation of vomiting, sleep
and adrenalin secretion and via the mostly pre-synaptically
located H3-autoreceptor modulating release of acetylcholine,
noradrenalin, and serotonin thus being involved in the regulation
of hunger, body temperature, and blood pressure (180).
Male ABA rats exhibited decreased H1 receptor binding in the
cortex, diencephalon and hippocampus; in contrast, decreased
H3 receptor binding in cortex and diencephalon due to an
acute forced swim test was normalized under conditions of ABA
(90). ABA gradually increased central (cortical, diencephalic,
and hippocampal) histamine levels and icv administration of
additional histamine reduced wheel running activity (90), giving
rise to the speculation that the upregulation of central histamine
represents a compensatory attempt to reduce hyperactivity.
Similarly, humans with AN also showed increased H1 receptor
binding in the amygdala and lentiform nucleus (181).
Pyrilamine (acute ip injection), an H1 receptor antagonist,
reduced locomotor activity during the dark period in ad libitum
fed mice, without exerting effects on food-anticipatory activity
under ABA conditions in mice (163).
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Noradrenaline
Noradrenaline, greatly expressed in the LC, affects various
functions including sleep-wake regulation, arousal, attention,
and memory (182). ABA in female rats activated LC neurons
compared to ad libitum fed rats as assessed using the neuronal
marker c-Fos (74).
Excessive exercise due to food restriction for 4 days in female
Sprague Dawley rats reduced cerebellar noradrenergic fiber
length, while exercise in general decreased inter-varicosity
interval length and increased varicosity density along
noradrenergic fibers (30). Rats that did not respond to the
ABA protocol, namely rats that suppressed food restriction-
evoked excessive exercise, displayed shortened inter-varicosity
intervals resulting in blunting of body weight loss (30). Whether
changes in fiber length and varicosity density are cause or result
of ABA should be evaluated in further research.
Increased locomotion as a response to food restriction is
still a barely understood phenomenon in AN. Therefore, further
investigations of the involvement of histamine and noradrenaline
might lead to possible strategies to counteract these changes.
Alterations in Anxiety and Anhedonia and
Respective Central Regulatory Areas
ABA in adolescent female mice decreased anxiety as assessed
using the elevated plus maze test with a negative correlation
between the time in open arms and food restriction-induced
wheel activity during the following 24 h; thus, mice displaying
high anxiety were hyperactive (183). Using the open field and
plus maze tests it was shown that female rats that underwent
ABA during adolescence displayed an increased anxiety-like
behavior in adulthood, whereas animals subjected to food
restriction alone did not (144). The ABA protocol performed
twice with 7 days in between in adolescent female rats induced
an increased long-term anxiety-like behavior in adulthood as
assessed by the elevated plus maze test (97). Animals showed
reduced ERbeta signaling in the amygdala using quantitative
real-time PCR; however, ovariectomy was unable to prevent
long-term behavioral changes (97). Strikingly, another study
showed no effect of ABA on anxiety-like behavior as assessed
using the elevated plus maze and open field test (49). Refeeding
without wheel access after ABA decreased horizontal activity and
exploratory horizontal behavior (13).
Male BDNF-Val66Met knock-in mice (BDNF Met/Met)
displayed a decreased activity-dependent BDNF secretion and
increased anxiety-like behavior (34). Strikingly, under ABA
conditions wildtype mice did not differ from BDNF Met/Met
mice regarding anxiety and lost GABAergic innervation along
distal dendrites in the hippocampal CA1 region and medial
prefrontal cortex (34). BDNF Met/Met mice showed reduced
food restriction-evoked hyperactivity (34) leading to the
hypothesis of blunted vulnerability to ABA.
Only one quarter of female ABA Sprague Dawley rats exhibit
transient anhedonia (enduring food restriction and hyperactivity,
disappearing during weight restoration) as assessed using the
sucrose preference paradigm (94). Noteworthy, exposure to a
running wheel correlated with an aversion to sweetened water,
and high levels of hyperactivity before food restriction correlated
with high susceptibility to body weight loss in ABA (94).
Additionally, food-anticipatory activity was related to subsequent
food intake only in body weight loss-resistant rats (94). No effect
of ABA on unconditioned lick responses to sucrose or quinine
or on preference for a diet high in fat could be observed in
female rats, indicating no alterations of taste responsivity in ABA
rats (49).
Since anxiety and other behavioral changes such as affective,
anxiety, obsessive-compulsive, and substance abuse disorders can
be observed in AN as well (3), the model also helps to assess these
comorbid conditions.
Alterations in Behavior
When examining operant responding for food reinforcers in
male albino ABA rats, each nose-poke response was reinforced
by a food pellet during the feeding phase resulting in a steeper
decrease in nose-poke response in ABA (84), indicating impaired
tolerant learning. ABA also induced an impairment in reversal
learning at low weight assessed using the attentional set-shifting
test with normalization following weight restoration in female
rats (82). ABA in adolescent female rats reduced performance
during the novel object recognition task but not in the novel
place recognition task or the Barnes maze (49), suggesting
impaired contextual but not spatial learning. The underlying
central mechanisms warrant further investigation in order to
potentially improve treatment of cognitive deficiency in AN.
After experiencing ABA during adolescence until a 25%
reduction of baseline body weight and following 10 days of
body weight regain, the acquisition of an aversion to sucrose
was accelerated and reinforced compared to female control
rats (50). Likewise, the extinction process was altered in post-
ABA female rats with a significant slowing of extinction in the
one bottle test where sucrose is presented for 5min without
following injection (50). These data might provide an underlying
mechanism contributing to the high relapse rate in AN (184).
Alterations of Peripheral Hormones
Oxytocin
In food deprived animals, oxytocin within the thymus was
decreased, likely due to reduced thymus gland weights also
observed under conditions of ABA (86). Similarly, in humans
serum oxytocin levels were reported to be decreased in AN
compared to healthy controls (185).
Corticosteroids
ABA in female Sprague Dawley rats led to higher baseline
corticosterone levels (48). Similarly, male and female ABA rats
displayed elevated circulating corticosterone concentrations
associated with higher relative adrenal gland weights, (86).
Interestingly, female rats that developed ABA during adolescence
presented increased anxiety-like behavior associated with
elevated plasma corticosterone (144). Wheel running induced by
hypophagia was absent in adrenalectomized male Lewis rats, a
finding reversible by corticosterone replacement (186). Similarly,
pre-prandial hyperactivity was diminished by adrenalectomy and
restored by acute corticosterone injection (186). Also, in humans
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with AN, cortisol concentrations were elevated (187), possibly
contributing to hyperactivity. The underlying mechanism
of corticosterone elevation in AN should be examined in
more detail.
Ghrelin
Plasma ghrelin levels in female mice were correlated with
food-anticipatory behavior observed as running activity under
conditions of ABA; conversely, female ghrelin receptor (GHS-
R1a) knockout mice did not anticipate food (presented as
percentage of total running wheel activity) (81). Similar effects
were observed in ABA mice treated either acutely icv or
chronically peripherally with a GHS-R1a antagonist that did
not show alterations in food intake (81). Additionally, food
restriction in ABA C57BL/6 male mice increased preproghrelin
mRNA-expressing cells in the stomach proportionally to body
weight loss (16). Single daily ip injection of ghrelin and
ghrelin combined with IgG from obese, but not lean mice,
prevented ABA in male C57BL/6 mice by decreasing physical
activity during the feeding period without diminishing body
weight loss and altering food-anticipatory activity (18). These
inconsistent data, showing decreased running activity under
ghrelin receptor knockout conditions as well due to exogenous
ghrelin application, could be a result of different routes of
application or protocols used. In summary, these results suggest
that ghrelin suppression might be an interesting target to tackle
hyperactivity in AN.
A study in C57BL/6J and DBA/2J inbred mouse lines showed
that food reduction leads to hypoleptinemia. The comparison of
both strains additionally showed that C57BL/6J mice reduced
wheel activity due to food restriction, while DBA/2J mice
displayed hyperactivity correlating with a stronger plasma leptin
decline, indicating that dynamic changes of plasma leptin have
a greater impact on the development of ABA than a simple
reduction of leptin levels (58).
In male Sprague Dawley rats the ABA paradigm was shown
to significantly reduce circulating leptin levels and increase
ghrelin levels (100). Especially in visceral and gonadal fat
leptin was absent (100). Interestingly, expression of ghrelin and
leptin (LEPR) receptors was tissue-specifically altered in ABA,
with increased GHS-R1a and LEPR expression in oxidative-
soleus type of muscle compared to the glycolytic-gastrocnemius
type (100). Additionally, GHS-R1a expression in visceral and
subcutaneous fat was stimulated by ABA, while the active long
form of LEPR was only expressed in subcutaneous fat (100).
Disturbed regulation of leptin and ghrelin as seen in ABA rats
has also been detected in AN patients (188, 189).
Female Reproductive Hormones
Restrictedly-fed female rats with access to wheels losing 25% of
body weight in 8 days developed a disruption in the estrous cycle,
an alteration restored after weight gain (47). Interestingly, while
hypoactivity developing during recovery from ABA disappeared
after resumption of estrous cycle, hyperphagia persisted but
was limited to nonestrous phases (47). The ABA paradigm
repeated twice in adolescent female rats with a 1-week interval in
between induced reduced estrogen receptor (ER) beta signaling
in the amygdala accompanied by anxiety-like behavior, long-term
behavioral changes that could not be prevented by ovariectomy
(97). In humans one of the main characteristics of AN is
the reduction in estradiol (E2) levels resulting in secondary
amenorrhea (190); consequently, this alteration should be
mimicked by and further investigated in ABA.
Allopregnanolone, a metabolite of progesterone, sc
administered during the 2nd food restriction period had
no effect on wheel running activity in mice sensitive to ABA.
In contrast, in ABA-resistant female C57BL6 mice it induced
increased running activity compared to a resistant group
receiving vehicle. Resistance was reflected by a reduction of
wheel running in the course of ABA (170).
Alterations of Glucose Homeostasis and
Energy Metabolism
In male ABA rats blood glucose levels and plasma insulin
concentrations were decreased compared to ad libitum fed or
exercising controls; however, peripheral IGF-2 concentrations
were elevated (154). Similarly, in male Sprague Dawley rats ABA
was shown to significantly reduce fat mass and increase insulin
sensitivity (100). Also, female Sprague Dawley rats showed lower
insulin levels (48). In male rats subjected to ABA, 2DG led to a
reduction of food intake, a finding similarly observed in weight-
matched controls suggesting a general effect of weight loss (39).
Since hypoglycemia can be a life-threatening consequence in AN
(191), the underlying mechanisms should be further examined.
ABA lowered body weight accompanied by an increase in
lean/fat mass ratio and fat oxidation in male C57BL/6 mice
(13). Refeeding with wheel access after the ABA protocol
restored fat free mass (13). In male Wistar rats, wheel running
activity reduced malondialdehyde, a degradation product of
polyunsaturated fatty acids and a marker of oxidative stress,
while food restriction decreased malondialdehyde plasma levels
along with antioxidant capacity in liver and catalase activity in
the gastrocnemius muscle (91). Additionally, the combination
of both, food restriction and access to running wheel, elevated
total antioxidant plasma levels but also reduced antioxidant
parameters in the liver and plasma malondialdehyde levels
compared to controls (91), presumably resulting from a reduced
need of antioxidant activity in the liver associated with a higher
plasma antioxidant capacity. Additionally, during refeeding after
development of ABA, female rats displayed a lower resting
energy expenditure and total energy expenditure resulting
in higher weight gain, although energy intake was lower
compared to controls (95). Although controls and ABA rats
maintained similar body weights, lipid accumulation in visceral
adipose tissue was reduced, while liver fat accumulation was
increased in post-ABA rats, probably caused by overfeeding with
carbohydrates (95). Therefore, the ABA model can also be used
to study the consequences of weight restoration in AN.
Interestingly, ABA mice exhibited an activation of
autophagy as assessed by increased dynamin-1 and
LC3II/LC3I ratio (21). This was observed in the soleus
muscle of ABA mice associated with reduced protein
synthesis, while in the anterior tibialis no alterations were
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observed. Compared to controls and restrictedly fed mice,
C57BL/6 ABA mice displayed a reduction in dihydrolipoyl
dehydrogenase and 3-mercaptopyruvate sulfurtransferase
and other mitochondrial proteins implicated in energy
metabolism (192).
Gastrointestinal Alterations
Comparing restrictively fed male C57Bl/6J ABA mice with
mice on a restricted feeding schedule ABA mice had a
thinner muscular layer and decreased claudin-1 expression
in the colon associated with increased colonic permeability
without differences in occludin expression or jejunal paracellular
permeability after 17 days (17). Refeeding after ABA for
5 days without wheel access elevated colonic permeability,
indicated by increased FITC-dextran flux compared to levels
during ABA. Refeeding with wheel access increased muscle
kynurenine conversion into kynurenic acid in male mice.
Conversion prevents kynurenine, producing oxygen radicals and
neurotoxins, to cross the blood-brain barrier, thus protecting
from stress-induced depression, indicating a benefit of physical
activity after ABA (13). Female C57Bl/6J ABA mice showed
elevated Toll-like receptor 4 (TLR4) mRNA expression on
colonic epithelial cells and intestinal macrophages, thus elevating
downstream mucosal cytokine production. Simultaneously,
hypothalamic interleukin-1β, interleukin-1R1, and interleukin-
1 receptor-associated kinase 4 as well as plasma corticosterone
levels were elevated (19). TLR4-deficient mice displayed a higher
mortality rate in response to the ABA protocol (19), suggesting
a dual effect of TLR4 in ABA: a key role in the early colonic
inflammation and a protective effect, since its absence can be
fatal. Noteworthy, ABA in female mice induced an alteration in
the colonic mucosal proteome, especially proteins implicated in
energy metabolism (192). The mammalian target of rapamycin
(mTOR) pathway was decreased inhibiting protein synthesis
(puromycin incorporation) and activating autophagy (192),
giving rise to an alteration of colonic mucosal proteome due to
the downregulation of energy metabolism.
ABA in female rats activated neurons of the NTS [involved
in the regulation of gastrointestinal motility (193)] compared to
ad libitum fed rats as assessed using the neuronal marker c-Fos
(74). In female ABA C57BL/6 mice, gastric emptying was delayed
compared to controls without food restriction and without wheel
access; similarly, animals with limited food access had delayed
gastric emptying (20). Food intake microstructure during the
feeding period in ABA did not differ from female animals without
access to a running wheel during food restriction (74).
In ABA mice, a downregulation of proteins of the antrum
was observed, namely ACTA2, VCL, KRT19, KRT8, and
DES, proteins implicated in the organization of muscle fiber
as well as heat shock proteins STIP1, HSPD1, and HSPA8
(20). Noteworthy, increased levels of gastric oxidized proteins
were detected in female ABA mice (20). A total of 52%
of rats that achieved a 30% weight loss due to ABA
displayed gastric lesions (44) independent of sex but possibly
associated with activity stress. Noteworthy, also in patients with
AN various gastrointestinal alterations have been described,
including decreased gastric emptying, impaired motility, and
permeability (194).
Alterations of the Immune System
Wheel running activity and food restriction increased spleen
weight and blastogenic response to lipopolysaccharide in
female mice (92). It also decreased serum corticosterone
levels, while food restriction alone increased corticosterone
levels; however, without a significant correlation between
serum corticosterone and any immune system measure (spleen
weight and blastogenic response to lipopolysaccharide) (92).
Exercise alone had no effect on in vivo antibody response
to sheep red blood cells and in vitro splenic responses
to concanavalin A and phytohemagglutinin (92). These
observations suggest that exercise might prevent undernutrition-
induced immunodepression similar to observations made in AN
patients (92).
OUTLOOK AND CONCLUSION
In summary, ABA induces alterations in different homeostatic
systems of the body (Figure 2). In the central nervous
system, ABA changes the activity pattern in the motor and
higher food intake circuitries as well as the expression of
neuropeptides including AgRP, NPY, POMC, and CART in
first-order neurons along with NMDA receptor expression.
Additionally, hypothalamic protein synthesis is increased. ABA
also modulates the GABAergic innervation and integrity of
hippocampal structures. The endocannabinoid transmission is
affected by ABA as well, along with an increased opioid
activity. In addition, abnormal reward signaling can be observed
under conditions of ABA. Regarding hormonal alterations, ABA
induced an elevation of vasopressin and reduction of oxytocin.
Cortisol and ghrelin concentrations are also elevated, while leptin
is reduced. Hormonal changes in the reproductive system disrupt
the estous cycle in ABA. Hypoglycemia and hypoinsulinemia
are accompanied by increased insulin sensitivity in ABA.
Functionally, decreased gastric emptying, increased permeability
and prevalence of gastric lesions as well as gut inflammation and
alterations in the colonic mucosal proteome, especially proteins
implicated in energy metabolism, are typical gastrointestinal
alterations found in ABA. Noteworthy, the physical activity in
ABA can prevent undernutrition-induced immunodepression.
It can be concluded that ABA in rodents shares various
similarities with AN in humans. However, as depicted in
Tables 1A,B, there is a great heterogeneity of the protocols
used to induce activity-based anorexia. Thus, results are often
difficult to compare, pointing toward a necessity to standardize
the protocol using a specific methodology regarding feeding
schedule, acclimatization and housing conditions in order to
obtain comparative studies.
To successfully reach the weight loss criterion in ABA, the
following methodological details should be regarded: animals
with a low body weight should be used, a period of wheel
adaptation should be included and food restriction prior to the
protocol should be omitted since ABA develops more likely when
wheel running interferes with adaptation to the feeding schedule
(which is avoided when the feeding schedule is introduced
before the running wheel). Additionally, a feeding schedule
for <2 h in rats with standard chow and ad libitum access
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FIGURE 2 | Alterations induced by activity-based anorexia. ↑, increase; ↓, decrease; =, no change.
to water is necessary to induce hyperactivity and weight loss.
Wheel access is crucial especially before food intake. Standard
temperature should be guaranteed and isolation should be
prevented in ABA, since it extends ABA duration by reducing
hyperactivity (54).
Noteworthy, the ABA model has also several limitations.
First, ABA only mimics some individuals with AN and not
those without hyperactivity, since it combines food restriction
and hyperactivity. Although hyperactivity is common in many
individuals with AN, it is not present in all cases and it is not
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FIGURE 3 | Comparison of different chronic activity-based anorexia protocols.
a diagnostic criterion. Thus, ABA is no exact replication of the
human disease. Second, when animals are placed in conditions
with restricted food access and unlimited wheel access as in
the present model, there are subgroups of animals who will not
engage in running at all; these animals thus preserve body weight
and can be maintained on restricted food access for a long time,
whereas other animals will fail to consume sufficient food during
the period of food access and will run themselves to death in
<1 week (28). Some research groups exclude animals that fail
to develop ABA; however, these animals that appear resistant
to ABA could serve as a control group. Another limitation
is the predominant use of male rodents in the ABA model
although the majority of AN patients is female. Lastly, also this
systematic review has limitations. Although the data search was
performed in three different databases, it cannot be excluded that
other relevant publications could not be identified and included.
Similarly, a keyword-based search also has flaws, since sometimes
keywords are omitted in publications. Moreover, articles in other
languages than English were not taken into consideration. Lastly,
for reasons of length and readability, not all results of the
included publications could be shown.
Since AN is a disease enduring in most cases over several
years and has a high relapse rate, in the last years few studies
focused on the establishment of a chronic ABAmodel in order to
mimic the pathological alterations in ANmore closely (Figure 3).
Comparing two protocols, one short-term over 15 days and
another over 55 days, in the latter anticipatory hyperactivity
was diminished over the course of the protocol, inducing also
a reduction of lean mass and body fat as well as reduction
of fat oxidation, preferential use of glucose to compensate for
the chronic energy imbalance, decrease of leptin levels, increase
of corticosterone, and ghrelin concentrations and a disruption
of the estrous cycle (14). Wheel access did not prevent loss
in bone mineral content due to food restriction and only the
long-term protocol induced bone parameters similar to those
observed in AN patients (14). Female adolescent rats that lost
20% of body weight due to ABA and subsequently exposed to an
additional 2-week weight holding phase displayed a significantly
disrupted menstrual cycle and E2 reduction compared to rats
whose menstrual cycle was assessed just after the 20% body
weight loss (195). Similarly, chronic starvation by food restriction
to 40% of the baseline food intake and 24 h/day running wheel
access until a 20–25% weight reduction followed by weight
holding due to individual food restriction, resulted in a loss of
the estrous cycle in all animals with 25% body weight loss, while
acute ABA disrupted estrous cycle only in 58% of rats (123).
In addition, due to the chronic ABA protocol in female rats
an impaired memory function was observed with a correlation
between E2 reduction and memory loss (195), possibly giving
rise to E2 substitution as therapeutic attempt to treat cognitive
deficits in AN. Chronic ABA also reduced the volumes of the
cerebral cortex and corpus callosum, Glial fibrillary acidic protein
positive astrocytes in these regions, total astrocyte-covered area
and astrocyte mRNA expression (196), alterations that likely
contribute to the neuropsychological deficits observed in AN.
Lastly, comparing different ages, 4-week old rats displayed
increased hyperactivity and amenorrhea compared to 8-week
old animals (123), indicating that younger animals are more
vulnerable to chronic ABA.
However, the chronic ABA models described above used
a method of food restriction that includes offering a certain
amount of food per day, which is different from the ABA
model as stated in the introduction. In the standard model
the animal is provided with an unlimited access to food for
a limited period of time and has to choose between food
intake and running wheel. In the amount-restricted model,
animals will typically consume all of the food provided, a
difference that should be kept in mind when comparing results.
It might be useful to establish a chronic model with time
restricted food access. Lastly, only a chronic protocol can
induce robust alterations of the menstrual cycle and bone
parameter, features also observed in AN. In the chronic protocol,
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female rodents seem more suited since they endure a longer
period without reaching the weight loss criterion (44, 120),
while males showed a higher mortality rate due to ABA
(13, 15). A chronic model including 4-week old rats losing
25% of body weight seems to most reliably display (chronic)
AN characteristics.
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